NCT06977191

Brief Summary

This study aims to investigate whether heart rate variability (HRV), a marker of autonomic nervous system activity, can predict the occurrence of rebound pain after total knee arthroplasty (TKA). Rebound pain is defined as a sudden and intense pain episode (NRS ≥7) that typically arises after the resolution of peripheral nerve blocks used for postoperative analgesia. Patients undergoing elective unilateral TKA under spinal anesthesia with peripheral nerve blocks will be included. HRV will be measured both before and after surgery using a chest-worn heart rate monitor. Pain levels, analgesic consumption, sleep quality, and patient satisfaction will also be recorded. The primary goal is to determine whether perioperative HRV values can serve as a predictive biomarker for rebound pain. Secondary outcomes include the relationship between HRV and pain intensity, opioid use, sleep quality, and length of hospital stay. The findings may contribute to developing individualized pain management strategies for TKA patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 18, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

May 20, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2025

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2025

Completed
Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

7 months

First QC Date

May 7, 2025

Last Update Submit

January 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Preoperative LF/HF Ratio as a Predictor of Rebound Pain

    To determine whether the preoperative low frequency to high frequency (LF/HF) ratio of heart rate variability is associated with the development of rebound pain after peripheral nerve block resolution. Patients will be classified based on the presence or absence of rebound pain (defined as a shift from NRS ≤3 to ≥7), and mean LF/HF ratios will be compared. Predictive capacity will be evaluated using logistic regression and ROC analysis.

    Preoperative (before spinal anesthesia) to 48 hours postoperative

Secondary Outcomes (1)

  • Association Between HRV Parameters and Pain Intensity

    0-48 hours postoperative

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients aged 18 to 70 years scheduled for elective unilateral total knee arthroplasty under spinal anesthesia at a tertiary care hospital. All participants will receive multimodal analgesia including peripheral nerve blocks as part of standard care.

You may qualify if:

  • Age between 18 and 70 years
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Scheduled for elective, unilateral total knee arthroplasty under spinal anesthesia
  • Planned use of multimodal analgesia including peripheral nerve blocks
  • Ability to provide written informed consent
  • Ability to understand and complete pain diaries and questionnaires

You may not qualify if:

  • Known allergy to local anesthetics
  • Contraindications to regional anesthesia
  • Contraindications to spinal anesthesia
  • ASA physical status IV or higher
  • Pregnancy or breastfeeding
  • Neurological or psychiatric disorders impairing ability to participate or report outcomes
  • Use of anticoagulant therapy or presence of coagulation disorders
  • Infection at the proposed injection site
  • Emergency (non-elective) surgical procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Konya City Hospital

Konya, 42090, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Mahmut Tutar, MD

    KONYA CITY HOSPİTAL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Department of Anesthesiology and Reanimation

Study Record Dates

First Submitted

May 7, 2025

First Posted

May 18, 2025

Study Start

May 20, 2025

Primary Completion

December 20, 2025

Study Completion

December 25, 2025

Last Updated

January 22, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

The individual participant data will not be shared due to institutional policy and patient confidentiality considerations.

Locations